CASI Pharmaceuticals
CASI
#11092
Rank
A$6.16 M
Marketcap
A$0.30
Share price
0.00%
Change (1 day)
-85.44%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -A$73.7 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$26.84 Million. In 2024 the company made an earning of -A$55.06 Million a decrease over its 2023 earnings that were of -A$38.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$73.7 Million33.85%
2024 -A$55.06 Million44.35%
2023 -A$38.15 Million-29.55%
2022 -A$54.14 Million4.43%
2021 -A$51.84 Million-24.56%
2020 -A$68.72 Million4.74%
2019 -A$65.61 Million65.13%
2018 -A$39.74 Million155.07%
2017 -A$15.58 Million13.93%
2016 -A$13.68 Million31.18%
2015 -A$10.43 Million-72.5%
2014 -A$37.9 Million356.62%
2013 -A$8.3 Million-60.55%
2012 -A$21.04 Million218.41%
2011 -A$6.61 Million0.74%
2010 -A$6.56 Million-32.54%
2009 -A$9.73 Million-66.98%
2008 -A$29.45 Million-14.22%
2007 -A$34.33 Million7.04%
2006 -A$32.07 Million27.95%
2005 -A$25.07 Million4.51%
2004 -A$23.98 Million-15.84%
2003 -A$28.5 Million-55.29%
2002 -A$63.73 Million-34.05%
2001 -A$96.64 Million31.73%
2000 -A$73.36 Million31.56%
1999 -A$55.76 Million145.56%
1998 -A$22.71 Million76.4%
1997 -A$12.88 Million36.92%
1996 -A$9.41 Million